Ad
ENZ Quote Trading Chart Enzo Biochem Inc.
Quote | Enzo Biochem Inc. (NYSE:ENZ)
| Last: | $0.3138 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $0.3702 |
| Close: | $0.3138 |
| High: | $0.4 |
| Low: | $0.3138 |
| Volume: | 4,123,861 |
| Last Trade Date Time: | 04/17/2025 04:00:02 pm |
Quotes are delayed by 15 to 20 minutes.
ENZ Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $0.3138 | $0.3702 | $0.3138 | $0.4 | $0.3138 | 4,123,861 | 04-18-2025 |
| $0.3138 | $0.3702 | $0.3138 | $0.4 | $0.3138 | 4,123,861 | 04-17-2025 |
| $0.3816 | $0.3259 | $0.3816 | $0.419 | $0.316 | 930,605 | 04-16-2025 |
| $0.336 | $0.331 | $0.336 | $0.38 | $0.325 | 580,825 | 04-15-2025 |
| $0.349 | $0.32 | $0.349 | $0.355 | $0.3 | 311,574 | 04-14-2025 |
| $0.324 | $0.286 | $0.324 | $0.325 | $0.286 | 580,157 | 04-11-2025 |
| $0.2608 | $0.33 | $0.2608 | $0.349 | $0.2608 | 531,818 | 04-10-2025 |
| $0.3341 | $0.3 | $0.3341 | $0.341 | $0.2828 | 1,102,449 | 04-09-2025 |
| $0.325 | $0.3 | $0.325 | $0.34 | $0.27 | 312,102 | 04-08-2025 |
| $0.2908 | $0.31 | $0.2908 | $0.3289 | $0.2612 | 525,889 | 04-07-2025 |
| $0.29 | $0.34 | $0.29 | $0.34 | $0.252 | 559,055 | 04-04-2025 |
| $0.3186 | $0.33 | $0.3186 | $0.34 | $0.3 | 346,154 | 04-03-2025 |
| $0.3325 | $0.3449 | $0.3325 | $0.36 | $0.31 | 435,590 | 04-02-2025 |
| $0.34 | $0.34 | $0.34 | $0.36 | $0.31 | 704,396 | 04-01-2025 |
| $0.37 | $0.3101 | $0.37 | $0.37 | $0.3101 | 918,753 | 03-31-2025 |
| $0.4313 | $0.4137 | $0.4313 | $0.451 | $0.4137 | 140,349 | 03-28-2025 |
| $0.4265 | $0.4364 | $0.4265 | $0.4675 | $0.4169 | 124,009 | 03-27-2025 |
| $0.44 | $0.46 | $0.44 | $0.4999 | $0.44 | 42,423 | 03-26-2025 |
| $0.47 | $0.49 | $0.47 | $0.49 | $0.453 | 60,855 | 03-25-2025 |
| $0.4899 | $0.49 | $0.4899 | $0.52 | $0.47 | 81,203 | 03-24-2025 |
News, Short Squeeze, Breakout and More Instantly...
Enzo Biochem Inc. Company Name:
ENZ Stock Symbol:
NYSE Market:
0.0% G/L:
$0.3138 Last:
4,123,861 Volume:
$0.3702 Open:
$0.3138 Close:
Enzo Biochem Inc. Website:
Ad
-
FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York Stock Exchange (“NYSE”) and to have its common stock quot...
-
FARMINGDALE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal second quarter ended January 31, 2025, with sequential quarter improvement in revenue, gross margin and opera...
-
Portage Biotech Inc. (PRTG) is expected to report for Q3 2025 Aimei Health Technology Co. Ltd (AFJK) is expected to report for quarter end 2024-12-31 Generation Bio Co. (GBIO) is expected to report $-0.28 for Q4 2024 TAT Technologies Ltd. (TATT) is expected to report for quarter end 2...
Important Investor News Alert (NASDAQ: CVKD)
-
LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascular (CV) events such as stroke Hospitalization costs for patients following a major bleeding event associated with oral anticoagulation use averages $39,000 per ev...